← Leaderboards
Diana Stevens
Research Triangle Institute
$1,675,696
Attributed
$1,675,696
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2019–22$2M$1.5M$1M$500K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$1,675,696 · 1
By mechanism
N01$1,100,191 · 1
N02$575,505 · 1
Top collaborators
No co-investigators on record.
Most similar at Research Triangle Institute
Same institution · by research overlap
- Bruce Blough$21,533,682
- Leah Johnson$11,180,070
- Elizabeth Trask Montgomery$5,464,924
- Rangan Maitra$14,311,381
- Wendee M Wechsberg$36,676,071
Others in their field
Other Emerging Leaders on “Tuberculosis Drugs”
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$30,845,607
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Timothy M Willson · University Of Cape Town$14,002,104
- Sujatha Rashid · American Type Culture Collection$10,735,388
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
Research focus
Tuberculosis DrugsCommunicable DiseasesDevelopment PlansDrug DiscoveryDrug KineticsEvaluationInterventional Agent DevelopmentIn VitroIn VivoLeadMicrobiologyToxinChemistryPathogenPre-ClinicalProduct DevelopmentProgramsSafetyServicesSupport ContractsTherapeutic DevelopmentToxicologyMycobacterium TuberculosisTuberculosis
Grant awards (3)
Task A02: Product Development Planning and Evaluation - The Lilly TB Drug Discovery Initiative$25,389
N02 · FY2022 · AI · contact PI
Task A02: Product Development Planning and Evaluation - The Lilly TB Drug Discovery Initiative$550,116
N02 · FY2021 · AI · contact PI
Task A02: Product Development Planning and Evaluation - The Lilly TB Drug Discovery Initiative$1,100,191
N01 · FY2019 · AI · contact PI